German health authority rejects added value of amyloid drugs in Alzheimer’s treatment
New research from Magdeburg suggests that memory loss in Alzheimer’s disease may not be permanent, challenging the long-held assumption that cognitive decline stems solely from irreversible brain cell death. A review of 17 studies involving over 20,000 participants found that widely used anti-amyloid drugs like Lecanemab reduce brain plaque but deliver minimal clinical benefit after … Weiterlesen …
